Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

173 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Enhanced T cell-independent antibody responses in c-Jun N-terminal kinase 2 (JNK2)-deficient B cells following stimulation with CpG-1826 and anti-IgM.
Cao Y, Takada E, Hata K, Sudo K, Furuhata M, Mizuguchi J. Cao Y, et al. Immunol Lett. 2010 Aug 16;132(1-2):38-44. doi: 10.1016/j.imlet.2010.05.006. Immunol Lett. 2010. PMID: 20665951
Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo.
Toyota H, Yanase N, Yoshimoto T, Harada M, Kato Y, Mizuguchi J. Toyota H, et al. Among authors: mizuguchi j. Oncol Rep. 2015 Jan;33(1):292-6. doi: 10.3892/or.2014.3603. Epub 2014 Nov 12. Oncol Rep. 2015. PMID: 25394516
C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines.
Mikami T, Koyama T, Koyama T, Imakiire A, Yamamoto K, Furuhata M, Toyota H, Mizuguchi J. Mikami T, et al. Anticancer Res. 2006 Mar-Apr;26(2A):1153-60. Anticancer Res. 2006. PMID: 16619517
STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production.
Owaki T, Asakawa M, Morishima N, Mizoguchi I, Fukai F, Takeda K, Mizuguchi J, Yoshimoto T. Owaki T, et al. J Immunol. 2008 Mar 1;180(5):2903-11. doi: 10.4049/jimmunol.180.5.2903. J Immunol. 2008. PMID: 18292512
173 results
Jump to page
Feedback